Pharmaceuticals

Occupational hygiene in the pharmaceutical industry is vital to ensure employees are not exposed to potential health threats related to exceeded exposure limits in pharmaceutical substances.

We provide routine analysis of occupational hygiene samples for substances for which validations have been undertaken as well as providing analysis for a wide range of other substances used in the pharmaceutical industry.

Pharmaceutical Analysis

We have developed and validated analytical methods for occupational hygiene samples for over 30 pharmaceutical actives including thiamine hydrochloride, taxmoxifen citrate, tacrolimus, pioglitazone hydrochloride, hydrochlorothiazide, candesartan cilexetil, tamulosin, famotidine, solifenacin succinate, S-isoquinoline, R-modafinal, mirabegon, spironolactone, ethinyloestradiol and norethisterone.

The validation process includes identifying appropriate sampling media and efficiency of recovery, sample stability, detection limits and analytical uncertainty.

What is Occupational Exposure Limits?

Related services include occupational hygiene monitoring and the provision of advice on in-house occupational exposure limits (OELs) for the pharmaceutical industry.

We have developed OELs for over 100 different actives for a number of clients in the pharmaceutical sector. Most of these have been substances that are in routine production but some have been for substances that are currently undergoing development and testing or substances used as starting materials or intermediates in the production process.

How our experts can help:

  • Provide analyses of occupational hygiene and pharmaceutical substances
  • Provide occupational hygiene monitoring
  • Provide advice on in-house occupational exposure limits


Contact: Carolyn McGonagle, 0131 449 8000, or complete the quick quote form below.

We're here to provide you with more information and answer any questions you may have. Contact us
  • IOMworld Posted: 3 days ago
    New research gives clear advice for employers on managing musculoskeletal disorders (MSDs) in the workplace.… https://t.co/VAjBtjom6w
  • IOMworld Posted: 3 days ago
    We have published over 2,500 articles and major pieces of project work. Today we are one of Europe’s principal work… https://t.co/t5Gc07YYP5
  • IOMworld Posted: 4 days ago
    One in four of the population suffer from chronic musculoskeletal disorders (MSDs). Discover good practice advice o… https://t.co/ENeRWMBlHA
  • IOMworld Posted: 4 days ago
    Restrict the transmission of the #COVID19 virus in the workplace with a #COVID19 workplace risk assessment. Find ou… https://t.co/15jhgFZpkd
  • IOMworld Posted: 17 days ago
    Last chance to get involved the future of healthy working by taking part in the EPHOR survey and be part of ground… https://t.co/T8Y5M84RuC
  • IOMworld Posted: 20 days ago
    Use your expert knowledge and be a part of ground-breaking research on developing innovative methods for working-li… https://t.co/FGcuKD0qHF
  • IOMworld Posted: 22 days ago
    Find out how you can help to advance occupational health science in a unique way to reduce the burden of disease. C… https://t.co/70Vl3Qv1EL
  • IOMworld Posted: 24 days ago
    We have published over 2,500 articles and major pieces of project work. Today we are one of Europe’s principal work… https://t.co/C2daujZVK7
  • IOMworld Posted: 25 days ago
    #NanoTox2021 is taking place online from 20th – 22nd April 2021 ➡️Nanotechnology ➡️ Hazard and risk assessment of n… https://t.co/JC30t6iKhf
  • IOMworld Posted: 26 days ago
    Talking about the physical and emotional aspects of working from home & how it impacts both organisations & humans… https://t.co/OYw7dsIvHF